Stocks in Play

Cardiome Pharma Corp.

11:49 AM EST - Cardiome Pharma Corp. : announced that a poster titled "Medical conversion with Vernakalant on postoperative cardio-surgical patients" by Thöne, M. et al., from the Department of Cardiovascular Surgery at the Heinrich-Heine-University Düsseldorf located in Düsseldorf,Germany, was presented at the 43rd Annual Meeting of the Germany Society for Thoracic and Cardiovascular Surgery held in Freiburg February 9-12. Cardiome Pharma Corp.
shares T.COM are trading up $0.57 at $9.57.